BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34850932)

  • 1. Financial toxicity in cancer care: origins, impact, and solutions.
    Abrams HR; Durbin S; Huang CX; Johnson SF; Nayak RK; Zahner GJ; Peppercorn J
    Transl Behav Med; 2021 Nov; 11(11):2043-2054. PubMed ID: 34850932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.
    Khera R; Valero-Elizondo J; Nasir K
    J Am Heart Assoc; 2020 Oct; 9(19):e017793. PubMed ID: 32924728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.
    Liang MI; Harrison R; Aviki EM; Esselen KM; Nitecki R; Meyer L
    Gynecol Oncol; 2023 Mar; 170():317-327. PubMed ID: 36758422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives.
    Fitch MI; Longo CJ
    Semin Oncol Nurs; 2021 Aug; 37(4):151174. PubMed ID: 34266710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial Toxicity of Cancer Care: It's Time to Intervene.
    Zafar SY
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review.
    Longo CJ; Fitch MI; Banfield L; Hanly P; Yabroff KR; Sharp L
    Support Care Cancer; 2020 Oct; 28(10):4645-4665. PubMed ID: 32653957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
    BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared burden: the association between cancer diagnosis, financial toxicity, and healthcare cost-related coping mechanisms by family members of non-elderly patients in the USA.
    Kazzi B; Chino F; Kazzi B; Jain B; Tian S; Paguio JA; Yao JS; Muralidhar V; Mahal BA; Nguyen PL; Sanford NN; Dee EC
    Support Care Cancer; 2022 Nov; 30(11):8905-8917. PubMed ID: 35877007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.
    Zafar SY; Peppercorn JM; Schrag D; Taylor DH; Goetzinger AM; Zhong X; Abernethy AP
    Oncologist; 2013; 18(4):381-90. PubMed ID: 23442307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer.
    Smith J; Yu J; Gordon LG; Chilkuri M
    Curr Oncol; 2023 May; 30(5):4922-4935. PubMed ID: 37232829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the Role of the Modern Oncology Provider in Mitigating Financial Toxicity.
    Su CT; Shankaran V
    J Am Coll Radiol; 2023 Jan; 20(1):51-56. PubMed ID: 36513257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial toxicity in cancer patients treated with radiotherapy in Germany-a cross-sectional study.
    Fabian A; Domschikowski J; Greiner W; Bockelmann G; Karsten E; Rühle A; Nicolay NH; Grosu AL; Dunst J; Krug D
    Strahlenther Onkol; 2022 Dec; 198(12):1053-1061. PubMed ID: 35467099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare system.
    Bauer AG; Jefferson M; Nahhas GJ; Savage S; Drake R; Lilly M; Ambrose L; Caulder S; Mahvi D; Hughes Halbert C
    Cancer Med; 2020 Dec; 9(23):8765-8771. PubMed ID: 33070458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unequal distribution of financial toxicity among people with cancer and its impact on access to care: a rapid review.
    Longo CJ; Fitch MI
    Curr Opin Support Palliat Care; 2021 Sep; 15(3):157-161. PubMed ID: 34232132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients.
    Waters AR; Biddell CB; Killela M; Kasow KA; Page K; Wheeler SB; Drier SW; Kelly MS; Robles J; Spees LP
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30700. PubMed ID: 37776093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A theoretical model of financial burden after cancer diagnosis.
    Jones SM; Henrikson NB; Panattoni L; Syrjala KL; Shankaran V
    Future Oncol; 2020 Dec; 16(36):3095-3105. PubMed ID: 32976048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial toxicity in thyroid cancer survivors.
    Bogdanovski AK; Sturgeon C; James BC
    Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):238-243. PubMed ID: 37470486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients.
    Fitch M; Longo CJ
    J Psychosoc Oncol; 2018; 36(5):582-596. PubMed ID: 30235067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How cancer programs identify and address the financial burdens of rural cancer patients.
    Petermann V; Zahnd WE; Vanderpool RC; Eberth JM; Rohweder C; Teal R; Vu M; Stradtman L; Frost E; Trapl E; Koopman Gonzalez S; Vu T; Ko LK; Cole A; Farris PE; Shannon J; Lee J; Askelson N; Seegmiller L; White A; Edward J; Davis M; Wheeler SB
    Support Care Cancer; 2022 Mar; 30(3):2047-2058. PubMed ID: 34655327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.